Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...

Shabbir Safdar, the executive director of the Partnership for Safe Medicines, an advocacy group that tracks counterfeit drugs, said fake GLP-1 medications are “the No. 1 fraud issue” that ...

For the first time in over a decade, obesity rates have dropped in the United States. A recent study by the CDC showed that ...

Kentucky leads the nation with 21 prescriptions per 1,000 residents, reflecting its 36.5% obesity rate and robust healthcare access.

Digital technologies loom large on the list—from the growing impact of artificial intelligence to the need for tech-enabled ...

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...

Months after posting weight loss of 7.5% at 36 days for patients taking MET-097i, Metsera releases mid-stage results of just ...

There are more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

Already, GLP-1 weight ... and Eli Lilly’s drug is more potent, and perhaps negotiations with national health services will also make it more cost-effective than Wegovy.” The list price of ...

Eli Lilly and Novo Nordisk, the main manufacturers in the field, are developing several weight loss drugs. CagriSema, for example, targets both GLP-1RA and an amylin receptor agonist (this mimics the ...

Are you looking for prescription drugs like Ozempic, Wegovy, and Mounjaro online? You’re not alone. However, shopping for medications on the Internet can be extremely risky. Dozens of unethical ...

Anti-obesity medications were a common topic of discussion this past year. While they may seem like a great option for weight loss, they aren’t appropriate for everyone, and they certainly come with ...